ClinConnect ClinConnect Logo
Search / Trial NCT04984005

The Interaction and Regulation Mechanism of Different Exercise Patterns With Metabolic Syndrome and Related Metabolic Diseases

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Jul 25, 2021

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Children And Adolescents Obesity Metabolic Syndrome Overweight Exercise

ClinConnect Summary

This clinical trial is studying how different types of exercise can help children and adolescents in China who are dealing with obesity or metabolic syndrome. Researchers want to find out which exercise patterns—like low intensity, moderate, or high intensity—are most effective at improving weight and other health factors related to metabolism. The trial will involve measuring changes in the participants' bodies using various methods, such as ultrasounds and analyzing blood and urine samples. The goal is to discover how exercise influences health and to develop the best exercise recommendations for young people facing these challenges.

To participate in this study, children and adolescents aged 9 to 18 who have been diagnosed with obesity or metabolic syndrome can join, as long as they can get permission from a guardian. It’s important that participants are able to understand the study and agree to take part. However, those with certain medical conditions, like Cushing syndrome or genetic obesity disorders, or those who have taken part in other studies recently, won’t be eligible. Participants can expect to be part of a supportive environment where their behavior and attitudes towards exercise will also be explored, helping to tailor effective exercise programs for their health needs.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of overweight or obesity or metabolic syndrome;
  • Good academic performance in school;
  • Willing to sign informed consent.
  • Exclusion Criteria:
  • Clinical diagnosis of Cushing syndrome;
  • Pathological obesity such as Prader-Willi syndrome and obesity caused by drug factors;
  • Participated in other intervention studies within the previous three months;
  • participant or their guardian has obvious intellectual or mental abnormalities.

About Peking University Third Hospital

Peking University Third Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare, innovative research, and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital emphasizes the integration of cutting-edge scientific research with patient-centered care to enhance therapeutic outcomes. With a multidisciplinary approach, the institution fosters collaboration among top-tier medical professionals and researchers, striving to contribute to the global medical community through rigorous clinical studies that address pressing health challenges. Its dedication to ethical standards and regulatory compliance ensures the safety and efficacy of new treatments, ultimately aiming to improve patient care and outcomes on both a national and international scale.

Locations

Beijing, Beijng, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials